CO4290359A1 - Metodo para tratar la alopecia androgenica con inhibidores 5-alfa-reductasa - Google Patents
Metodo para tratar la alopecia androgenica con inhibidores 5-alfa-reductasaInfo
- Publication number
- CO4290359A1 CO4290359A1 CO94046672A CO94046672A CO4290359A1 CO 4290359 A1 CO4290359 A1 CO 4290359A1 CO 94046672 A CO94046672 A CO 94046672A CO 94046672 A CO94046672 A CO 94046672A CO 4290359 A1 CO4290359 A1 CO 4290359A1
- Authority
- CO
- Colombia
- Prior art keywords
- alpha
- androgenic alopecia
- reductase inhibitors
- treating androgenic
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
- A61Q7/02—Preparations for inhibiting or slowing hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Abstract
REIVINDICACION NUMERO UN METODO PARA TRATAR LA ALOPECIA ANDROGENICA, QUE SUPONE ADMINISTRAR A UNA PERSONA QUE NECESITA TAL TRATAMIENTO, UN INHIBIDOR 5-ALFA-REDUCTASA 2, EN UNA CANTIDAD DOSIFICIADA POR DEBAJO DE LOS 5.0 mg/ dia.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13852093A | 1993-10-15 | 1993-10-15 | |
US08/214,905 US5547957A (en) | 1993-10-15 | 1994-03-17 | Method of treating androgenic alopecia with 5-α reductase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
CO4290359A1 true CO4290359A1 (es) | 1996-04-17 |
Family
ID=22482390
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO94046672A CO4290359A1 (es) | 1993-10-15 | 1994-10-12 | Metodo para tratar la alopecia androgenica con inhibidores 5-alfa-reductasa |
Country Status (8)
Country | Link |
---|---|
US (4) | US5547957A (es) |
EP (1) | EP0776664A2 (es) |
KR (1) | KR100375083B1 (es) |
CO (1) | CO4290359A1 (es) |
HK (1) | HK1000933A1 (es) |
MY (2) | MY123960A (es) |
YU (1) | YU49026B (es) |
ZA (1) | ZA948064B (es) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW382595B (en) * | 1993-10-15 | 2000-02-21 | Merck & Co Inc | Pharmaceutical composition for use in arresting and reversing androgenic alopecia |
US5547957A (en) * | 1993-10-15 | 1996-08-20 | Merck & Co., Inc. | Method of treating androgenic alopecia with 5-α reductase inhibitors |
US5739137A (en) * | 1993-10-21 | 1998-04-14 | Merck & Co., Inc. | 16-substituted-4-aza-3-oxo-androstane as 5-alpha-reductase isozyme 1 inhibitors |
USRE39056E1 (en) | 1995-09-15 | 2006-04-04 | Merck & Co, Inc. | 4-Azasteroids for treatment of hyperandrogenic conditions |
WO1997014418A1 (en) * | 1995-10-19 | 1997-04-24 | Merck & Co., Inc. | 16-substituted-6-aza-steroid 5-alpha-reductase inhibitors |
US5679378A (en) * | 1995-12-18 | 1997-10-21 | Olim Industries Of Israel, North America, Ltd. | Method and material for hair therapy |
US5935968A (en) | 1997-03-17 | 1999-08-10 | Merck & Co., Inc. | Methods for treating polycystic ovary syndrome |
US6348348B1 (en) * | 1998-04-07 | 2002-02-19 | The Carnegie Institution Of Washington | Human hairless gene and protein |
US6645974B2 (en) | 2001-07-31 | 2003-11-11 | Merck & Co., Inc. | Androgen receptor modulators and methods for use thereof |
EP1451144B1 (en) | 2001-10-31 | 2010-09-01 | Coreana Cosmetics Co., Ltd. | Compositions for treating acne comprising phytandiol amine |
GB0213745D0 (en) * | 2002-06-14 | 2002-07-24 | Univ Edinburgh | Enzyme |
US7790706B2 (en) * | 2002-06-14 | 2010-09-07 | The University Of Edinburgh | Treatment of inflammation with 5α reduced metabolites |
IL156670A0 (en) * | 2003-06-26 | 2004-01-04 | Zvi Zolotariov | Aloe suppositories |
ATE406376T1 (de) * | 2003-07-03 | 2008-09-15 | Cipla Ltd | Verfahren zur herstellung von finasterid form i |
US20050136015A1 (en) * | 2003-12-17 | 2005-06-23 | McKie Derrick B. | Topical use of halosalicylic acid derivatives |
JP2007522201A (ja) * | 2004-02-12 | 2007-08-09 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | 毛成長の刺激方法 |
GB0407329D0 (en) * | 2004-03-31 | 2004-05-05 | Danisco | Process |
US7979110B1 (en) * | 2004-09-23 | 2011-07-12 | Orbital Research Inc. | Method for accurate placement of electrodes |
US7998970B2 (en) | 2004-12-03 | 2011-08-16 | Proteosys Ag | Use of finasteride, dutasteride and related compounds for the prevention or treatment of neurologically-associated disorders |
US20060263452A1 (en) * | 2005-05-17 | 2006-11-23 | Alwyn Dowell | Topical composition containing essential oils |
US20070167899A1 (en) * | 2006-01-19 | 2007-07-19 | Strom Randy A | Compression apparatus and method for stimulating hair growth |
US20090076058A1 (en) * | 2007-09-17 | 2009-03-19 | Protia, Llc | Deuterium-enriched finasteride |
US20090203628A1 (en) * | 2008-02-12 | 2009-08-13 | Jan Marini | Composition, Method And Kit For Treating Skin Disorders And Improving Skin Condition |
US20090233954A1 (en) * | 2008-03-12 | 2009-09-17 | Goren Andy Ofer | Methods and systems for prognosis of a patient's response to treatment of androgenetic skin disorders |
EP2378872A4 (en) | 2008-12-18 | 2012-05-16 | B Eugene Guthery | TREATMENT PLAN FOR ACNE VULGARIS |
FR2954124B1 (fr) * | 2009-12-18 | 2012-04-06 | Fabre Pierre Dermo Cosmetique | Utilisation du 2,3-dihydroxypropyl dodecanoate pour le traitement de la seborrhee |
BR112013002697A2 (pt) * | 2010-08-05 | 2016-05-31 | Legacy Healthcare Holding Ltd | método para estimular o crescimento do cabelo |
US8604047B2 (en) * | 2010-08-10 | 2013-12-10 | Elorac, Inc. | Method and composition for treating nodulocystic and conglobate acne vulgaris |
EP2782582A4 (en) * | 2011-11-25 | 2016-09-28 | Adrianna Janell Jackson | OIL COMPOSITIONS AND METHODS FOR PROMOTING HAIR GROWTH AND / OR PREVENTING HAIR LOSS |
KR102064488B1 (ko) * | 2019-04-18 | 2020-01-13 | 주식회사 엠진 | 홍삼 추출물 등을 이용한 발모 촉진 또는 탈모 억제용 조성물 |
KR102221365B1 (ko) | 2019-05-07 | 2021-03-02 | (주)케어젠 | 트롤록스-펩타이드 결합체 및 그의 용도 |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU527030B2 (en) * | 1978-04-13 | 1983-02-10 | Merck & Co., Inc. | 4-aza-17-substituted-5a-androstan-3-ones |
US4377584A (en) * | 1978-04-13 | 1983-03-22 | Merck & Co., Inc. | 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors |
US4220775A (en) * | 1979-03-15 | 1980-09-02 | Merck & Co., Inc. | Preparation of 4-aza-17-substituted-5α-androstan-3-ones useful as 5α-reductase inhibitors |
US4396615A (en) * | 1981-06-24 | 1983-08-02 | Duke University | Method of treating androgen-related disorders |
US4885289A (en) * | 1983-12-12 | 1989-12-05 | Breuer Miklos M | Alteration of character of male beard growth |
US5120742A (en) * | 1984-02-27 | 1992-06-09 | Merck & Co., Inc. | 17 β-acyl-4-aza-5 α-androst-1-ene-3-ones as 5 α-reductase inhibitors |
US4859681A (en) * | 1984-02-27 | 1989-08-22 | Merck & Co., Inc. | 17 α-Acyl-4-aza-5a-androst-1-en-3-ones as 5 alpha-reductase inhibitors |
US4760071A (en) * | 1984-02-27 | 1988-07-26 | Merck & Co., Inc. | 17β-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-ones which are active as testosterone 5α-reductase inhibitors |
US5151429A (en) * | 1984-02-27 | 1992-09-29 | Merck & Co., Inc. | 17β-acyl-4-aza-5α-androst-1-ene-3-ones as 5α reductase inhibitors |
US5571817A (en) * | 1984-02-27 | 1996-11-05 | Merck & Co., Inc. | Methods of treating androgenic alopecia with finasteride [17β-N-mono-substituted-carbamoyl-4-aza-5-α-androst-1-en-ones] |
US5049562A (en) * | 1984-02-27 | 1991-09-17 | Merck & Co., Inc. | 17β-acyl-4-aza-5α-androst-1-ene-3-ones as 5α-reductase inhibitors |
NZ211145A (en) * | 1984-02-27 | 1988-10-28 | Merck & Co Inc | 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions |
US5053403A (en) * | 1984-05-11 | 1991-10-01 | Norman Orentreich | Methods for treatment of male-pattern baldness |
US4684635A (en) * | 1984-05-11 | 1987-08-04 | Norman Orentreich | Compositions and methods for inhibiting the action of androgens |
EP0285382B1 (en) * | 1987-04-03 | 1994-04-13 | Merck & Co. Inc. | Treatment of androgenic alopecia with 17beta-n-monosubstituted-carbamoyl-4-aza-5alpha-androst-1-en-3-ones |
DE3888378T2 (de) | 1987-04-03 | 1994-09-29 | Merck & Co Inc | Behandlung von Prostatacarcinoma mit 17-beta-n-monosubstituierten-Carbamoyl-4-aza-5-alpha-Androst-1-en-3-onen. |
US5228431A (en) * | 1990-04-26 | 1993-07-20 | Giarretto Ralph R | Drug-free method for treatment of the scalp for therapeutic purposes |
US5162332A (en) * | 1990-06-20 | 1992-11-10 | Merck & Co., Inc. | Selected 17 β-polyaroyl-4-aza-5 α-androst-1-en-3-ones as steroidal reductase inhibitors |
US5098908A (en) * | 1990-06-20 | 1992-03-24 | Merck & Co., Inc. | 17β-hydroxybenzoyl-4-aza-5α-androst-1-en-3-ones as testosterone reductase inhibitors |
DK0542802T3 (da) * | 1990-08-10 | 1996-07-22 | Upjohn Co | Stimulering af hårvækst med kaliumkanalåbnere og 5alfa-reduktase-inhibitorer |
US5175155A (en) * | 1991-10-07 | 1992-12-29 | Sterling Winthrop Inc. | Win 49596-finasteride method of use and compositions |
CA2135173A1 (en) | 1992-05-20 | 1993-11-25 | Bruce E. Witzel | Ester derivatives of 4-aza-steroids |
RU2141967C1 (ru) * | 1992-05-21 | 1999-11-27 | Андорешерш Инк. | ИНГИБИТОРЫ ТЕСТОСТЕРОН 5α-РЕДУКТАЗЫ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И СПОСОБ ИНГИБИРОВАНИЯ АКТИВНОСТИ ТЕСТОСТЕРОН 5α-РЕДУКТАЗЫ |
US5795882A (en) * | 1992-06-22 | 1998-08-18 | Bone Care International, Inc. | Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations |
US5407944A (en) | 1993-02-19 | 1995-04-18 | Goldman; Boris E. | Compositions and methods for promoting hair growth |
DE69405760T2 (de) * | 1993-06-28 | 1998-04-09 | Merck & Co Inc | 4-aza-pregnan-5-alpha-reductase isozym 1 inhibitoren |
US5438061A (en) | 1993-07-16 | 1995-08-01 | Merck & Co., Inc. | 7-substituted-δ4-6-azasteroid derivatives as 5α-reductase inhibitors |
TW369521B (en) * | 1993-09-17 | 1999-09-11 | Smithkline Beecham Corp | Androstenone derivative |
US5547957A (en) * | 1993-10-15 | 1996-08-20 | Merck & Co., Inc. | Method of treating androgenic alopecia with 5-α reductase inhibitors |
TW382595B (en) * | 1993-10-15 | 2000-02-21 | Merck & Co Inc | Pharmaceutical composition for use in arresting and reversing androgenic alopecia |
US5739137A (en) * | 1993-10-21 | 1998-04-14 | Merck & Co., Inc. | 16-substituted-4-aza-3-oxo-androstane as 5-alpha-reductase isozyme 1 inhibitors |
US5708001A (en) * | 1993-12-17 | 1998-01-13 | Glaxo Wellcome Inc. | Substituted 6-azaandrostenones |
US5525608A (en) * | 1994-04-20 | 1996-06-11 | Merck & Co., Inc. | 17b-aryl-4-aza-steroid derivatives useful as 5-alpha-reductase inhibitors |
US5512555A (en) | 1994-07-21 | 1996-04-30 | Merck & Co., Inc. | Method of treating sweat-related conditions using finasteride, epristeride and a cholestan-3-one |
US5543417A (en) * | 1994-10-21 | 1996-08-06 | Merck & Co., Inc. | Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents |
US5595996A (en) | 1994-10-25 | 1997-01-21 | Merck & Co., Inc. | 7-substituted 4-aza cholanic acid derivatives and their use |
WO1997014418A1 (en) * | 1995-10-19 | 1997-04-24 | Merck & Co., Inc. | 16-substituted-6-aza-steroid 5-alpha-reductase inhibitors |
US5763361A (en) * | 1995-10-23 | 1998-06-09 | Merck & Co., Inc. | 17-alkyl-7-substituted-4-aza steroid derivatives as 5-α-reductase inhibitors |
US5777134A (en) * | 1995-10-26 | 1998-07-07 | Merck & Co., Inc. | 4-oxa and 4-thia steriods |
US5756507A (en) * | 1995-12-14 | 1998-05-26 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US5780437A (en) * | 1995-12-14 | 1998-07-14 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US5849764A (en) * | 1995-12-14 | 1998-12-15 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
-
1994
- 1994-03-17 US US08/214,905 patent/US5547957A/en not_active Expired - Lifetime
- 1994-10-06 MY MYPI98003259A patent/MY123960A/en unknown
- 1994-10-06 MY MYPI94002641A patent/MY138240A/en unknown
- 1994-10-07 YU YU58394A patent/YU49026B/sh unknown
- 1994-10-11 KR KR1019960701921A patent/KR100375083B1/ko not_active IP Right Cessation
- 1994-10-11 EP EP97200134A patent/EP0776664A2/en not_active Withdrawn
- 1994-10-12 CO CO94046672A patent/CO4290359A1/es unknown
- 1994-10-14 ZA ZA948064A patent/ZA948064B/xx unknown
-
1997
- 1997-12-15 HK HK97102425A patent/HK1000933A1/xx not_active IP Right Cessation
-
1999
- 1999-11-24 US US09/448,930 patent/US6174892B1/en not_active Expired - Fee Related
-
2000
- 2000-10-30 US US09/699,906 patent/US6355649B1/en not_active Expired - Fee Related
-
2001
- 2001-12-07 US US10/010,678 patent/US20020042425A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US6174892B1 (en) | 2001-01-16 |
YU58394A (en) | 1999-11-22 |
MY123960A (en) | 2006-06-30 |
HK1000933A1 (en) | 1998-05-08 |
MY138240A (en) | 2009-05-29 |
EP0776664A3 (es) | 1997-06-11 |
KR960704555A (ko) | 1996-10-09 |
US20020042425A1 (en) | 2002-04-11 |
EP0776664A2 (en) | 1997-06-04 |
US5547957A (en) | 1996-08-20 |
US6355649B1 (en) | 2002-03-12 |
ZA948064B (en) | 1995-06-06 |
YU49026B (sh) | 2003-07-07 |
KR100375083B1 (ko) | 2003-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO4290359A1 (es) | Metodo para tratar la alopecia androgenica con inhibidores 5-alfa-reductasa | |
ES2163504T3 (es) | Formas de dosificacion de liberacion controlada de azitromicina. | |
MXPA03003960A (es) | Combinaciones de farmacos (v.gr., clorpromazina y pentamidina) para el tratamiento de desordenes neoplasticos. | |
ES2165990T3 (es) | Thip para el tratamiento de trastornos del sueño. | |
AR034746A1 (es) | Combinaciones para el tratamiento de trastornos inflamatorios | |
BG106461A (en) | Methods and use of rapid onset of reactive serotonin inhibitors for treating sexual dysfunction | |
EP1628667A4 (en) | METHOD FOR TREATING DISEASES USING HSP90 INHIBITION AGENTS COMBINED WITH ANTIMITOTICS | |
DE3583887D1 (de) | Ausruestung fuer die behandlung der osteoporose. | |
ES2166001T3 (es) | Utilizacion de compuestos antimineralcorticoides contra el sindrome de abstinencia de narcoticos. | |
GR3023448T3 (en) | Pyridylguanidine compounds for treatment of erectile dysfunction. | |
ES2187156T3 (es) | Terapia antidepresiva. | |
ES2186153T3 (es) | Sulfato de 5-alfa-pregnan-3-beta-ol-20-ona para el tratamiento de tumores y de los trastornos del snc. | |
MX9206135A (es) | Metodos | |
ES2113549T3 (es) | Metodo para inhibir la replicacion de vih empleando il-4. | |
ES2097816T5 (es) | Producto y su uso para el tratamiento de estados catabolicos que comprende ifg-1 autentico y cantidades hipocaloricas de nutrientes. | |
EP1009421A4 (en) | PROCESS AND COMPOSITIONS FOR IMPROVED Wounds Healing | |
AR005866A1 (es) | Composicion farmaceutica antioxidante | |
IL126158A0 (en) | Method for treating substance abuse | |
PL328949A1 (en) | Method of treatng excessive aggression | |
MY118982A (en) | Method of reducing tissue damage associated with ischemia | |
UA10754A (uk) | Спосіб лікуваhhя артеріальhих гіпертеhзій різhого геhезу | |
UA36137A (uk) | Спосіб лікування хворих на хронічне легеневе серце | |
MD1296G2 (ro) | Metoda Nicolau de tratament al lichenului plan bucal | |
UA41376C2 (uk) | ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ТА СПОСІБ ЛІКУВАННЯ АНДРОГЕННОЇ АЛОПЕЦІЇ ІНГІБІТОРАМИ 5-<font face="Symbol">a</font>-РЕДУКТАЗИ | |
DE69428276D1 (de) | Insulinähnlicher wachstumfaktor ii als antitumormittel |